Jim Cramer on Vertex (VRTX): “A Revolutionary Anti-Pain Drug”
We recently published a list of Jim Cramer Discusses These 10 Stocks & Says US Faces Unfairly High Tariffs Abroad. In this ...
The Motley Fool on MSN13d
Where Will Vertex Pharmaceuticals Be in 10 Years?
Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic ...
Vertex price target raised to $60 from $57 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Vertex (VERX) to $60 from $57 and keeps an Overweight rating on the shares. The company’s ...
Vertex, Inc. to Host 2025 Investor Day
Vertex, Inc. (NASDAQ: VERX) today announced that it will host an Investor Day on Wednesday, March 19, in Philadelphia, PA.
Swiss National Bank Increases Holdings in Vertex, Inc. (NASDAQ:VERX)
Swiss National Bank raised its stake in Vertex, Inc. (NASDAQ:VERX – Free Report) by 7.3% during the 4th quarter, ...